Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).
Ryu MH, Lee KH, Shen L, Yeh KH, Yoo C, Hong YS, Park YI, Yang SH, Shin DB, Zang DY, Kang WK, Chung IJ, Kim YH, Ryoo BY, Nam BH, Park YS, Kang YK.
Ryu MH, et al. Among authors: chung ij.
Cancer Med. 2023 Apr;12(7):7784-7794. doi: 10.1002/cam4.5536. Epub 2022 Dec 14.
Cancer Med. 2023.
PMID: 36515003
Free PMC article.
Clinical Trial.